Logo

Gencell Licenses SAS Software

Feb 25, 2004

NEW YORK, Feb. 25 (GenomeWeb News) - SAS has licensed its Scientific Discovery Solutions software to Gencell, the company said today.

 

Gencell, a subsidiary of Aventis Pharma, will use the package, including SAS Research Data Management, SAS Microarray Solution, and SAS Enterprise Miner, to analyze and manage gene expression data, to handle data from clinical trials, and to develop electronic filings to health authorities.

 

Last month, Bristol-Myers Squibb said it will test SAS software for gene expression analysis and proteomics.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.